PSICOFARMACOLOGIA ON-LINE

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

(Requiere estar conectado a internet. Haga un click en la información del journal)

Executive and prefrontal dysfunction in unipolar depression: a review of neuropsychological and imaging evidence

Mark A. Rogers, Kiyoto Kasai, Matsuo Koji, Rinmei Fukuda, Akira Iwanami, Kazuyuki Nakagome, Masato Fukuda and Nobumasa Kato
Neuroscience Research. Volume 50, Issue 1 , September 2004, Pages 1-11

Acute Stress Disorder, Posttraumatic Stress Disorder, and Depression in Disaster or Rescue Workers

Carol S. Fullerton, Robert J. Ursano, and Leming Wang

Am J Psychiatry 161:1370-1376, August 2004

Posttraumatic Stress Disorder and Depression Following Trauma: Understanding Comorbidity

Meaghan L. O’Donnell, Mark Creamer, and Phillipa Pattison

Am J Psychiatry 161:1390-1396, August 2004

The ACTH Response to Dexamethasone in PTSD

Rachel Yehuda, Julia A. Golier, Sarah L. Halligan, Michael Meaney, and Linda M. Bierer

Am J Psychiatry 161:1397-1403, August 2004

Impact of Sleep Deprivation and Subsequent Recovery Sleep on Cortisol in Unmedicated Depressed Patients

Ulrich Voderholzer, Fritz Hohagen, Torsten Klein, Julia Jungnickel, Clemens Kirschbaum, Mathias Berger, and Dieter Riemann

Am J Psychiatry 161:1404-1410, August 2004

Prospective Study of Clinical Predictors of Suicidal Acts After a Major Depressive Episode in Patients With Major Depressive Disorder or Bipolar Disorder

Maria A. Oquendo, Hanga Galfalvy, Stefani Russo, Steven P. Ellis, Michael F. Grunebaum, Ainsley Burke, and J. John Mann

Am J Psychiatry 161:1433-1441, August 2004

Correlates of 1-Year Prospective Outcome in Bipolar Disorder: Results From the Stanley Foundation Bipolar Network

Willem A. Nolen, David A. Luckenbaugh, Lori L. Altshuler, Trisha Suppes, Susan L. McElroy, Mark A. Frye, Ralph W. Kupka, Paul E. Keck, Jr., Gabriele S. Leverich, and Robert M. Post

Am J Psychiatry 161:1447-1454, August 2004

Differential Response to Placebo Among Patients With Social Phobia, Panic Disorder, and Obsessive-Compulsive Disorder

Jonathan D. Huppert, Luke T. Schultz, Edna B. Foa, David H. Barlow, Jonathan R.T. Davidson, Jack M. Gorman, M. Katherine Shear, H. Blair Simpson, and Scott W. Woods

Am J Psychiatry 161:1485-1487, August 2004

Impact of stressful life events, familial loading and their interaction on the onset of mood disorders

Study in a high-risk cohort of adolescent offspring of parents with bipolar disorder

MANON H. J. HILLEGERS, HUIBERT BURGER, MARJOLEIN WALS, CATRIEN G. REICHART, FRANK C. VERHULST, WILLEM A. NOLEN, JOHAN ORMEL

The British Journal of Psychiatry (2004) 185: 97-101

Subjective experience of electroconvulsive therapy

Susan M. Benbow, Joe Crentsil

Psychiatric Bulletin (2004) 28: 289-291

Identification of somatic and anxiety symptoms which contribute to the detection of depression in primary health care

Katrin Barkow, Reinhard Heun, T. Bedirhan Üstün, Mathias Berger, Isaac Bermejo, Wolfgang Gaebel, Martin Härter, Frank Schneider, Rolf-Dieter Stieglitz and Wolfgang Maier
European Psychiatry.Volume 19, Issue 5, August 2004, Pages 250-257

One-year course of the first vs. multiple episodes of depression—Polish naturalistic study

Janusz K. Rybakowski, Dorota Nawacka and Andrzej Kiejna
European Psychiatry.Volume 19, Issue 5, August 2004, Pages 258-263

Dimensions of mania: differences between mixed and pure episodes

Ana González-Pinto, Ana Aldama, Asunción González Pinto, Fernando Mosquera, José Luis Pérez de Heredia, Javier Ballesteros and Miguel Gutiérrez
European Psychiatry.Volume 19, Issue 5 , August 2004, Pages 307-310

Brain choline concentrations may not be altered in euthymic bipolar disorder patients chronically treated with either lithium or sodium valproate
Ren H Wu, Tina O'Donnell, Michele Ulrich, Sheila J Asghar, Christopher C Hanstock and Peter H Silverstone
Annals of General Hospital Psychiatry 2004, 3:13

Neural and Behavioral Responses to Tryptophan Depletion in Unmedicated Patients With Remitted Major Depressive Disorder and Controls

Alexander Neumeister, Allison C. Nugent, Tracy Waldeck, Marilla Geraci, Markus Schwarz, Omer Bonne, Earle E. Bain, David A. Luckenbaugh, Peter Herscovitch, Dennis S. Charney, Wayne C. Drevets

Arch Gen Psychiatry. 2004;61:765-773.

Relationships Among Plasma Dehydroepiandrosterone Sulfate and Cortisol Levels, Symptoms of Dissociation, and Objective Performance in Humans Exposed to Acute Stress

Charles A. Morgan III, Steve Southwick, Gary Hazlett, Ann Rasmusson, Gary Hoyt, Zoran Zimolo, Dennis Charney

Arch Gen Psychiatry. 2004;61:819-825.

Absence of discontinuation symptoms with agomelatine and occurrence of discontinuation symptoms with paroxetine: a randomized, double-blind, placebo-controlled discontinuation study.
Montgomery, S. A.; Kennedy, S. H.; Burrows, G. D.; Lejoyeux, M.; Hindmarch, I.

International Clinical Psychopharmacology. 19(5):271-280, September 2004

Mixed states in bipolar II disorder: should full hypomania always be required?

Franco Benazzi
Psychiatry Research. Volume 127, Issue 3, 15 July 2004, Pages 247-257

Incidence and Duration of Side Effects and Those Rated as Bothersome With Selective Serotonin Reuptake Inhibitor Treatment for Depression: Patient Report Versus Physician Estimate

X. Henry Hu, Scott A. Bull, Enid M. Hunkeler, Eileen Ming, Janelle Y. Lee, Bruce Fireman, Leona E. Markson

J Clin Psychiatry 2004;65:959-965

Are Illness Concepts a Powerful Predictor of Adherence to Prophylactic Treatment in Bipolar Disorder?

Nikolaus Kleindienst, Waldemar Greil

J Clin Psychiatry 2004;65:966-974

The Effectiveness of Olanzapine, Risperidone, Quetiapine, and Ziprasidone as Augmentation Agents in Treatment-Resistant Major Depressive Disorder

James G. Barbee, Erich J. Conrad, and Nowal J. Jamhour

J Clin Psychiatry 2004;65:975-981

Antidepressant-Withdrawal Mania: A Critical Review and Synthesis of the Literature

Chittaranjan Andrade

J Clin Psychiatry 2004;65:987-993

Citalopram as Treatment of Depression in Patients With Epilepsy.
Specchio LM, Iudice A, Specchio N, La Neve A, Spinelli A, Galli R, Rocchi R, Ulivelli M, De Tommaso M, Pizzanelli C, Murri L.

Clin Neuropharmacol. 2004 May-Jun;27(3):133-136.

Aripiprazole: in acute mania associated with bipolar I disorder.
Lyseng-Williamson KA, Perry CM.

CNS Drugs. 2004;18(6):367-76; discussion 377-8.

Intravenous antidepressants: a review.
Moukaddam NJ, Hirschfeld RM.

Depress Anxiety. 2004;19(1):1-9.

Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: Randomised, double-blind, placebo-controlled, fixed-dose study.
Lader M, Stender K, Burger V, Nil R.

Depress Anxiety. 2004;19(4):241-8.

Population pharmacokinetic analysis of mirtazapine.
Grasmader K, Verwohlt PL, Kuhn KU, Dragicevic A, Von Widdern O, Zobel A, Hiemke C, Rietschel M, Maier W, Jaehde U, Rao ML.

Eur J Clin Pharmacol. 2004 Jul 29 [Epub ahead of print]

Sad, blue, or depressed days, health behaviors and health-related quality of life, Behavioral Risk Factor Surveillance System, 1995-2000
Rosemarie Kobau, Marc A Safran, Matthew M Zack, David G Moriarty and Daniel Chapman
Health and Quality of Life Outcomes 2004, 2:40

Evolutionary origins of depression: a review and reformulation

Daniel Nettle

Journal of Affective Disorders. Volume 81, Issue 2, August 2004, Pages 91-102

Evaluating the inter-episode stability of depressive mixed states

Tetsuya Sato, Ronald Bottlender, Marcus Sievers, Andreas Schröter, Nikolaus Kleindienst and Hans-Jürgen Möller

Journal of Affective Disorders. Volume 81, Issue 2, August 2004, Pages 103-113

Interpersonal functioning deficits: temporary or stable characteristics of depressed individuals?

Scharles Cercy Petty, Natalie Sachs-Ericsson, and Thomas E. Joiner, Jr.

Journal of Affective Disorders. Volume 81, Issue 2, August 2004, Pages 115-122

Consistency of remission and outcome in bipolar and unipolar mood disorders: a 10-year prospective follow-up

Joseph F. Goldberg and Martin Harrow

Journal of Affective Disorders. Volume 81, Issue 2, August 2004, Pages 123-131

Is the risk of bipolar disorder in twins equal to the risk in singletons? A nationwide register-based study

Ulla Kläning, Thomas Munk Laursen, Rasmus W. Licht, Kirsten Ohm Kyvik, Axel Skytthe and Preben Bo Mortensen

Journal of Affective Disorders. Volume 81, Issue 2, August 2004, Pages 141-145

Clinical application of low serum cholesterol as an indicator for suicide risk in major depression

Yong-Ku Kim and Aye-Mu Myint

Journal of Affective Disorders. Volume 81, Issue 2, August 2004, Pages 161-166

Modafinil treatment in patients with seasonal affective disorder/winter depression: an open-label pilot study

Leslie Lundt

Journal of Affective Disorders. Volume 81, Issue 2, August 2004, Pages 173-178

Why do some individuals develop social phobia? A review with emphasis on the neurobiological influences
Maria Tillfors

Nordic Journal of Psychiatry. Volume 58, Number 4 / June 2004: 267 - 276

Gender differences in the psychopathology of depressed inpatients

D. Winkler, E. Pjrek A. Heiden, G. Wiesegger, N. Klein, A. Konstantinidis and S. Kasper

European Archives of Psychiatry and Clinical Neuroscience 2004; Volume 254, Number 4: 209 - 214

Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment

Murad Atmaca, E. Tezcan, M. Kuloglu, B. Ustundag and H. Tuncko

European Archives of Psychiatry and Clinical Neuroscience 2004; Volume 254, Number 4: 231 - 235

Reduced serotonin transporter–availability in obsessive–compulsive disorder (OCD)

K. Stengler-Wenzke, U. Müller, M. C. Angermeyer, O. Sabri and S. Hesse

European Archives of Psychiatry and Clinical Neuroscience 2004; Volume 254, Number 4: 252 - 255

Identification of somatic and anxiety symptoms which contribute to the detection of depression in primary health care.
Barkow K, Heun R, Ustun TB, Berger M, Bermejo I, Gaebel W, Harter M, Schneider F, Stieglitz RD, Maier W.
Eur Psychiatry. 2004 Aug;19(5):250-7.

Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction

Marika T. Granfors, Janne T. Backman, Mikko Neuvonen, Jouni Ahonen and Pertti J. Neuvonen

Clinical Pharmacology & Therapeutics.Volume 75, Issue 4, April 2004, Pages 331-341

Bipolar Patients With Suicidal Behavior: Toward the Identification of a Clinical Subgroup

Frederic Slama, Frank Bellivier, Chantal Henry, Angela Rousseva, Bruno Etain, Frederic Rouillon, and Marion Leboyer

J Clin Psychiatry 2004;65:1035-1039

A Double-Blind, Randomized, Placebo-Controlled Trial of Quetiapine Addition in Patients With Obsessive-Compulsive Disorder Refractory to Serotonin Reuptake Inhibitors

Damiaan Denys, Femke de Geus, Harold J. G. M. van Megen, and Herman G. M. Westenberg

J Clin Psychiatry 2004;65:1040-1048

"Dopamine-Dependent" Side Effects of Selective Serotonin Reuptake Inhibitors: A Clinical Review

Cristian Damsa, Anja Bumb, Francesco Bianchi-Demicheli, Pierre Vidailhet, Robert Sterck, Antonio Andreoli, and Stefan Beyenburg

J Clin Psychiatry 2004;65:1064-1068

Serum Folate, Vitamin B₁₂, and Homocysteine in Major Depressive Disorder, Part 1: Predictors of Clinical Response in Fluoxetine-Resistant Depression

George I. Papakostas, Timothy Petersen, David Mischoulon, Julie L. Ryan, Andrew A. Nierenberg, Teodoro Bottiglieri, Jerrold F. Rosenbaum, Jonathan E. Alpert, and Maurizio Fava

J Clin Psychiatry 2004;65:1090-1095

The Effectiveness of St. John's Wort in Major Depressive Disorder: A Naturalistic Phase 2 Follow-Up in Which Nonresponders Were Provided Alternate Medication

Alan J. Gelenberg, Richard C. Shelton, Paul Crits-Christoph, Martin B. Keller, David L. Dunner, Robert M. A. Hirschfeld, Michael E. Thase, James M. Russell, R. Bruce Lydiard, Robert J. Gallop, Linda Todd, David J. Hellerstein, Paul J. Goodnick, Gabor I. Keitner, Stephen M. Stahl, Uriel Halbreich, and Heather S. Hopkins

J Clin Psychiatry 2004;65:1114-1119

Impact of Comorbid Anxiety Disorders on Outcome in a Cohort of Patients With Bipolar Disorder

Khrista R. Boylan, Peter J. Bieling, Michael Marriott, Helen Begin, L. Trevor Young, and Glenda M. MacQueen

J Clin Psychiatry 2004;65:1106-1113

Risperidone does not affect steady-state pharmacokinetics of divalproex sodium in patients with bipolar disorder.
Ravindran A, Silverstone P, Lacroix D, Van Schaick E, Vermeulen A, Alexander J.

Clin Pharmacokinet. 2004;43(11):733-40.

The serotonin transporter polymorphism, 5HTTLPR, is associated with a faster response time to sertraline in an elderly population with major depressive disorder
L. Kathryn Durham, Suzin M. Webb, Patrice M. Milos, Cathryn M. Clary and Albert B. Seymour
Psychopharmacology 2004; Volume 174, Number 4: 525 - 529

From molecular biology to pharmacogenetics: a review of the literature on antidepressant treatment and suggestions of possible candidate genes

Alessandro Serretti and Paola Artioli

Psychopharmacology 2004; Volume 174, Number 4: 490 - 503

Genetic features of antidepressant induced mania and hypo-mania in bipolar disorder

Alessandro Serretti, Paola Artioli, Raffaella Zanardi, Cristina Lorenzi, David Rossini, Cristina Cusin, Alessia Arnoldi and Marco Catalano

Psychopharmacology 2004; Volume 174, Number 4: 504 - 511

Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study

Paul D. Arnold, David R. Rosenberg, Emanuela Mundo, Subi Tharmalingam, James L. Kennedy and Margaret A. Richter

Psychopharmacology 2004; Volume 174, Number 4: 530 - 538

Chronic carbamazepine selectively downregulates cytosolic phospholipase A₂ expression and cyclooxygenase activity in rat brain

Sandra Ghelardoni, York A. Tomita, Jane M. Bell, Stanley I. Rapoportand Francesca Bosetti

Biological Psychiatry.Volume 56, Issue 4, 15 August 2004, Pages 248-254

Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder

Louise Heuzenroeder ; Marie Donnelly ; Michelle M. Haby ; Cathrine Mihalopoulos ; Ruth Rossell ; Rob Carter ; Gavin Andrews ; Theo Vos

Australian and New Zealand Journal of Psychiatry 2004;Volume: 38 Number: 8 Page: 602 -- 612

Antioxidant enzyme and malondialdehyde values in social phobia before and after citalopram treatment.
Atmaca M, Tezcan E, Kuloglu M, Ustundag B, Tunckol H.

Eur Arch Psychiatry Clin Neurosci. 2004 Aug;254(4):231-5

Hippocampal neurochemical pathology in patients at first episode of affective psychosis: a proton magnetic resonance spectroscopic imaging study

Giuseppe Blasia

, Alessandro Bertolino, Flora Brudaglio, Domenico Sciota, Mario Altamura, Nicola Antonucci, Tommaso Scarabino, Daniel R. Weinberger and Marcello Nardini

Psychiatry Research: Neuroimaging. Volume 131, Issue 2, 30 July 2004, Pages 95-105

Transcranial magnetic stimulation (TMS) of the human frontal cortex: implications for repetitive TMS treatment of depression

Tomáš Paus and Jennifer Barrett

J Psychiatry Neurosci. 2004 July; 29 (4): 268–279

The therapeutic role of 5-HT_1A and 5-HT_2A receptors in depression

Pau Celada, M. Victoria Puig, Mercè Amargós-Bosch, Albert Adell, and Francesc Artigas

J Psychiatry Neurosci. 2004 July; 29 (4): 252–265

Preventing Postpartum Depression Part I: A Review of Biological Interventions

Cindy-Lee E Dennis

Can J Psychiatry 2004;49:467–475

Clonazepam for Treatment of Sleep Disturbances Associated with Combat-Related Posttraumatic Stress Disorder

Marshall E Cates, Melanie H Bishop, Lori L Davis, Joette S Lowe, Thomas W Woolley

The Annals of Pharmacotherapy: Vol. 38, No. 9, pp. 1395-1399

Cardiovascular effects of selective serotonin reuptake inhibitor antidepressants
Pacher P, Kecskemeti V.

Orv Hetil. 2004 Feb 22;145(8):425-31.

Preferential 5-HT_1A Autoreceptor Occupancy by Pindolol is Attenuated in Depressed Patients: Effect of Treatment or an Endophenotype of Depression?
Eugenii A Rabiner, Zubin Bhagwagar, Roger N Gunn, Philip J Cowen and Paul M Grasby

Neuropsychopharmacology (2004) 29, 1688-1698

A Preliminary fMRI Study of Sustained Attention in Euthymic, Unmedicated Bipolar Disorder
Stephen M Strakowski, Caleb M Adler, Scott K Holland, Neil Mills and Melissa P DelBello

Neuropsychopharmacology (2004) 29, 1734-1740

DSM-IV obsessive-compulsive personality disorder: Prevalence in patients with anxiety disorders and in healthy comparison subjects

Umberto Albert, Giuseppe Maina, Federica Forner, Filippo Bogetto

Comprehensive Psychiatry September-October 2004 • Volume 45 • Number 5

Alexithymia and suicidal ideation: A 12-month follow-up study in a general population

Jukka Hintikka, Kirsi Honkalampi, Heli Koivumaa-Honkanen, Risto Antikainen, Antti Tanskanen, Kaisa Haatainen, Heimo Viinamäki

Comprehensive Psychiatry September-October 2004 • Volume 45 • Number 5

Escitalopram doseresponse revisited: an alternative psychometric approach to evaluate clinical effects of escitalopram compared to citalopram and placebo in patients with major depression.
Bech P, Tanghj P, Cialdella P, Andersen HF, Pedersen AG.

Int J Neuropsychopharmacol. 2004 Sep;7(3):283-90

Stress and hippocampal abnormalities in psychiatric disorders

M. Sala, J. Perez, P. Soloff, S. Ucelli di Nemi, E. Caverzasi, J. C. Soares and P. Brambilla